ARS Pharmaceuticals, Inc. insider trading

SPRYNASDAQ

$4.29+0.22 (+5.41% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (-58.2%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Unlock quarterly net flow

Key players

STSarina TanimotoCHIEF MEDICAL OFFICER11.4162%of company
RERichard E. LowenthalPRESIDENT AND CEO11.366%of company
PSPratik ShahDirector4.4994%of company
LSLaura ShawverDirector0.2115%of company
AAAlexander A. FitzpatrickChief Legal Officer0.0914%of company
KDKathleen D. ScottChief Financial Officer0.0184%of company
EKEric KarasChief Commercial Officer0.0122%of company
BDBrian DorseyChief Operating Officer0.0108%of company
BLBrent L. SaundersDirector0.00%of company
JCJustin ChakmaChief Business Officer0.00%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
SPRY	Alexander A. FitzpatrickChief Legal Officer	Open market sell$33.6K	-3.6%	$10.00	$33.6K	Jun 12, 2026	Jun 12, 2026

End of history · 1 transactions